Unlike the Eygptian god, this Osiris seeks to keep people out of the afterlife. The biotech company researches, develops, and markets cellular regenerative drug candidates. It engages in stem cell research, bioengineering, and the development of tissue-based products. Its marketed products include treatments in the areas of orthopedics, sports medicine, and wound care, Bone repair and regeneration allograft Bio4 is a viable bone matrix and alternative to autografts (the transfer of tissue from one part of the body to another). Other products include allograft Cartiform, placental membrane Grafix, skin allograft TruSkin, and placental allograft Stravix.